Licensing Partner of Shenzhen Chipscreen Biosciences - HUYABIO International, Receives Regulatory Approval for Chidamide Monotherapy of Peripheral T-Cell Lymphoma(PTCL) in Japan
/PRNewswire/ -- Shenzhen Chipscreen Biosciences licensing partner, HUYABIO International (HUYABIO™), today announced the regulatory approval for Chidamide...
Kensei Tobinai Chidamide Tucidinostat Chipscreen Bioscience Chipscreen Biosciences Lu Xianping Mireille Gillings
Source: prnewswire.com